Militia Capital Management LLC Acquires Shares of 270,397 Sotera Health Company $SHC

Militia Capital Management LLC acquired a new position in Sotera Health Company (NASDAQ:SHC) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 270,397 shares of the company’s stock, valued at approximately $3,877,000. Sotera Health makes up 0.9% of Militia Capital Management LLC’s investment portfolio, making the stock its 20th biggest position.

A number of other large investors have also recently modified their holdings of the stock. CenterBook Partners LP increased its position in shares of Sotera Health by 94.1% during the fourth quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock valued at $2,673,000 after buying an additional 73,473 shares during the period. Capricorn Fund Managers Ltd purchased a new stake in Sotera Health in the fourth quarter worth about $7,936,000. Nordea Investment Management AB bought a new stake in Sotera Health during the 4th quarter valued at approximately $1,908,000. Retirement Systems of Alabama boosted its position in Sotera Health by 16.9% during the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock valued at $4,391,000 after acquiring an additional 35,974 shares in the last quarter. Finally, Exchange Traded Concepts LLC purchased a new position in shares of Sotera Health during the 4th quarter worth approximately $7,739,000. Institutional investors own 91.03% of the company’s stock.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 15.36% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Piper Sandler reissued an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Weiss Ratings upgraded Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. The Goldman Sachs Group initiated coverage on Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 price objective for the company. UBS Group set a $19.00 target price on shares of Sotera Health in a report on Wednesday, June 24th. Finally, Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Stock Performance

Sotera Health stock opened at $17.29 on Thursday. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. The company has a market capitalization of $4.93 billion, a P/E ratio of 42.17 and a beta of 1.76. The stock’s 50 day moving average is $16.57 and its 200 day moving average is $16.39. Sotera Health Company has a twelve month low of $11.00 and a twelve month high of $19.85.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. During the same quarter in the previous year, the business earned $0.14 earnings per share. The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities research analysts predict that Sotera Health Company will post 0.87 earnings per share for the current fiscal year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.